Compounds > 19-nortestosterone 17-hemisuccinate
Page last updated: 2024-11-06
19-nortestosterone 17-hemisuccinate
Description
19-nortestosterone 17-hemisuccinate, also known as nandrolone hemisuccinate, is a synthetic anabolic-androgenic steroid (AAS) that is a derivative of testosterone. It is primarily used as a medication to treat conditions such as anemia and osteoporosis. The drug is typically administered via injection. It is often used in veterinary medicine for treating conditions related to growth, development, and reproductive health. 19-nortestosterone 17-hemisuccinate, like other AAS, can be used to improve athletic performance and build muscle mass. Due to its potential for abuse and side effects, its use in sports is banned.'
19-nortestosterone 17-hemisuccinate: increases solubility of nandrolone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 94333 |
SCHEMBL ID | 17419472 |
MeSH ID | M0186435 |
Synonyms (18)
Synonym |
19-nortestosterone 17-hemisuccinate |
6785-62-2 |
4-[[(8r,9s,10r,13s,14s,17s)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid |
7ikf7ww60t , |
einecs 229-849-7 |
unii-7ikf7ww60t |
17beta-hydroxyestr-4-en-3-one 17-(3-carboxypropionate) |
nandrolone succinate |
nandrolone hemisuccinate |
succinic acid 19-nortestosterone monoester |
nandrolone hydrogen succinate |
estr-4-en-3-one, 17.beta.-hydroxy-, hydrogen succinate |
stenoplex |
19-nortestosterone succinate |
succinic acid, monoester with 17.beta.-hydroxyestr-4-en-3-one |
SCHEMBL17419472 |
DTXSID70987197 |
Q27268353 |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.50 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.29 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |